Searched for
INTERNATIONAL FORMULATIONS REVENUE
Private equity firm Creador in talks to buy into generic drug co Leeford HealthPrivate equity firm Creador is in advanced talks to acquire a stake. The firm expects to invest ₹800 crore in Leeford Healthcare. This acqu...04 Aug, 2026, 01.04 AM IST- MOFSL stays bullish on Sun Pharma; sees 16% upside on innovation pipelineSun Pharma's June quarter results met analyst expectations, signaling future growth. The company is expanding its specialty and innovative ...03 Aug, 2026, 06.30 AM IST
- Sun Pharma Q1 Results: Profit rises 27% YoY to Rs 2,895 crore; revenue climbs 10.5%Sun Pharma Q1 Results: Sun Pharma reported a 27% YoY rise in Q1 net profit to Rs 2,895 crore, while revenue grew 10% to Rs 15,300 crore, dr...31 Jul, 2026, 03.37 PM IST
- BDR Pharmaceuticals eyes controlling stake in Acme FormulationPAG acquired a controlling stake in Acme Formulation for $145 million (?1,054 crore) through its PAG Asia III buyout fund in 2021. Founder ...28 Jul, 2026, 11.49 PM IST
- Ahead of Diwali season: Central Pollution Control Board opposes 'green crackers' production over prohibited barium nitrate usage; SC to settle the disputeSupreme Court will decide whether next-generation green firecrackers can be commercially produced in India after two central government bod...27 Jul, 2026, 05.19 PM IST
- When Being a Family Business Becomes a Competitive AdvantageFamily businesses often underestimate the strategic power of their familial identity, defaulting instead to corporate models that erode the...20 Jul, 2026, 01.06 PM IST
- Iceberg bets on organic sourcing and clean labels to build a Rs 100-cr ice cream brandAs India's premium ice cream market shifts from calorie-counting to ingredient-conscious consumption, Iceberg Organic Ice Creams is betting...13 Jul, 2026, 10.36 AM IST
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 25%As the market makes an attempt to move upward, there is a clear preference for sectors that are focused on the domestic market. Given this,...06 Jul, 2026, 07.15 PM IST
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsIn just a few days, the Q1 earnings season for FY27 will start. But before that will come the season of business updates. And that needs to...03 Jul, 2026, 12.49 PM IST
- For investors looking beyond the short-term horizon: 5 mid-cap stocks from different sectors with upside potential up to 28%All is once again quiet on the US-Iran war front, and some kind of dialogue to resolve the issues between the two seems to be still underwa...30 Jun, 2026, 02.54 PM IST
- Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 28%It is quite likely that the news cycle this and the next week will be about the direction of US interest rates and yield. If that turns out...29 Jun, 2026, 04.05 PM IST
- These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...26 Jun, 2026, 11.31 AM IST
- These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...19 Jun, 2026, 11.50 AM IST
- What Maruti-Suzuki can teach India-JapanThe Maruti-Suzuki collaboration brought global manufacturing to India, democratising transportation and boosting the middle class. This par...15 Jun, 2026, 08.17 PM IST
- Manipur CM urges NITI Aayog to drive state's recovery and developmentManipur Chief Minister Yumnam Khemchand Singh urged NITI Aayog to spearhead the state's economic recovery and long-term development, emphas...12 Jun, 2026, 11.49 PM IST
- PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stakePrivate equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...09 Jun, 2026, 08.48 PM IST
- Promoter sells Rs 1,024 crore worth of Ajanta Pharma shares in block deal to Kotak MF and ABSL MFA promoter entity of Ajanta Pharma sold shares worth over Rs 1,024 crore through a block deal, with Kotak Mahindra Mutual Fund and Aditya B...09 Jun, 2026, 07.34 PM IST
Load More
